Glenmark Life Science's Q4 profit jumped 48% YoY to Rs146 crore, while revenue from operations rose 21% YoY to Rs621 crore. Its EBITDA grew 45.2% YoY to Rs206.4 crore with 33.2% margins YoY, benefiting from high CDMO contribution, better product mix, PLI sche…